MedTrace Logo

Metformin Use and Clinical Pregnancy Rate in Women With Unexplained Infertility

NCT03681197 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2019-03-21

No results posted yet for this study

Summary

The aim of this study is to asses the effect of metformin on clinical pregnancy rate in women with unexplained infertility (randomized controlled trial).

This study will be conducted in infertility clinic,Ain Shams university maternity hospital,170 women with unexplained infertility will be enrolled in this study.

Statistical analysis of the data will be performed .

Conditions

Interventions

DRUG

Metformin

Metformin 850 mg tablet will be started twice daily immediately at booking time and continued with induction by clomiphene citrate, it will be stopped once pregnancy is confirmed.

DRUG

Placebo

In placebo group,placebo will be strted twice daily at booking time and continued with induction by clomiphene citrate, it will be stopped once pregnancy is confirmed.

DRUG

Clomiphene Citrate

50 mg of clomiphene citrate will be given starting day 2 of menstrual cycle for 5 days

Sponsors & Collaborators

  • Elham Raafat

    lead OTHER

Principal Investigators

  • Sarah S Moawad, Lecturer · Ain Shams Maternity Hospital

  • Ahmed M Bahaa Eldin, Professor · Ain Shams Maternity Hospital

  • Hisham M Fathy, Professor · Ain Shams Maternity Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2019-04-30
Completion
2019-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681197 on ClinicalTrials.gov